4//SEC Filing
Cadista Holdings Inc. 4
Accession 0001209191-14-077594
CIK 0001521762operating
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 10:39 AM ET
Size
13.8 KB
Accession
0001209191-14-077594
Insider Transaction Report
Form 4
Jubilant Life Sciences Ltd.
10% Owner
Transactions
- Purchase
Common Stock
2014-12-22$1.60/sh+20,753,606$33,205,770→ 117,797,190 total(indirect: See footnotes)
Jubilant Life Sciences Holdings Inc.
10% Owner
Transactions
- Purchase
Common Stock
2014-12-22$1.60/sh+20,753,606$33,205,770→ 117,797,190 total(indirect: See footnotes)
Jubilant Pharma Pte Ltd
10% Owner
Transactions
- Purchase
Common Stock
2014-12-22$1.60/sh+20,753,606$33,205,770→ 117,797,190 total(indirect: See footnotes)
Bhartia Shyam S.
10% Owner
Transactions
- Purchase
Common Stock
2014-12-22$1.60/sh+20,753,606$33,205,770→ 117,797,190 total(indirect: See footnotes)
Bhartia Hari S.
10% Owner
Transactions
- Purchase
Common Stock
2014-12-22$1.60/sh+20,753,606$33,205,770→ 117,797,190 total(indirect: See footnotes)
Footnotes (4)
- [F1]The Reporting Persons and Jubilant Generics Inc., f/k/a Generic Pharmaceuticals Holdings Inc. ("JGI"), previously reported the ownership of 97,043,574 shares of common stock of Cadista Holdings Inc. ("Cadista") pursuant Form 3s filed with the Securities and Exchange Commission (the "SEC").
- [F2]17,018,378 additional shares were acquired pursuant to a tender offer, commenced on November 13, 2014 (the "Tender Offer") for all issued and outstanding shares of Cadista not already owned by JGI and its affiliates, upon and subject to the conditions set forth in the Offer to Purchase, dated November 13, 2014, as amended and supplemented (as amended and supplemented, the "Offer to Purchase"), which was annexed to and filed with the Tender Offer Statement and Rule 13E-3 Transaction Statement originally filed under cover of Schedule TO by certain of the Reporting Persons with the SEC on November 13, 2014.
- [F3]The Tender Offer expired at 5:00 p.m. on December 19, 2014, and on December 22, 2014, as contemplated by the Offer to Purchase, JGI effectuated a short-form merger (the "Merger"), pursuant to which JGI was merged with and into Cadista, and Cadista became a wholly-owned subsidiary of Jubilant Pharma Holdings Inc. ("JPH"), which had owned all of the shares of capital stock of JGI at the effective time of the Merger. The shares reported as owned by the Reporting Persons reflects the share ownership of Cadista after the effectiveness of the Merger. All reported securities are owned directly by JPH. JPH is owned by Jubilant Pharma Ltd. ("JPL"). JPL is a wholly-owned subsidiary of Jubilant Life Sciences Ltd. ("JLS").
- [F4]Shyam S. Bhartia and Hari S. Bhartia, who are brothers, own or control a significant percentage of the equity shares of JLS, and accordingly may be deemed to indirectly own the reported shares. Messrs. Shyam S. Bhartia and Hari S. Bhartia disclaim any beneficial ownership of any shares owned indirectly by JLS, except to the extent of their respective pecuniary interests therein.
Documents
Issuer
Cadista Holdings Inc.
CIK 0001521762
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001521762
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 10:39 AM ET
- Size
- 13.8 KB